NON-SEDATING DEXMEDETOMIDINE TREATMENT REGIMENS
卷宗概要
申请人
BioXcel Therapeutics, Inc.
发明人
Vasukumar KAKUMANU; David Christian HANLEY; Frank YOCCA; Chetan Dalpatbhai LATHIA; Lavanya RAJACHANDRAN; Robert RISINGER
IPC 分类
CPC 分类
Disclosed herein are methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without also inducing significant sedation. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases such as schizophrenia, bipolar illness such as bipolar disorder or mania, dementia, depression, or delirium.
原文（中文）
Disclosed herein are methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without also inducing significant sedation. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases such as schizophrenia, bipolar illness such as bipolar disorder or mania, dementia, depression, or delirium.